Glaxosmithkline | Resultado Líquido



Net Income Alterar Data
AbbVie USD 1.29B 1.31B 2025-03
Amgen USD 627M 2.2B 2024-12
AstraZeneca USD 2.92B 1.42B 2025-03
Aurora Cannabis CAD 31.67M 43.71M 2024-12
Bausch Health Companies USD -58000000 151M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Canopy Growth CAD -121896000 6.4M 2024-12
Corcept Therapeutics USD 30.75M 16.47M 2024-12
Drreddys Laboratories INR 14.13B 1.58B 2024-12
Eli Lilly USD 2.76B 1.65B 2025-03
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Glaxosmithkline GBP 414M 472M 2024-12
Indivior 48M 11M 2025-03
J&J USD 11B 7.57B 2025-03
Merck USD 5.08B 1.34B 2025-03
Novartis USD 2.82B 371M 2024-12
Pacira USD 16.04M 159.51M 2024-12
Perrigo USD -44500000 23.5M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Prestige Brands USD 61.03M 6.65M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12
Takeda JPY 23.79B 68.26B 2024-12
Teva Pharmaceutical Industries USD -217000000 220M 2024-12
Zoetis USD 581M 101M 2024-12



Glaxosmithkline Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.